KOGENATE Side Effects

7001099-9 | Factor Viii Inhibition, Haematoma, Haemophilia
on Sep 15, 2010 Male patient from FRANCE , 72 years of age, was treated with Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition, haematoma, haemophilia. Kogenate dosage: .

6707586-2 | Loss Of Consciousness, Malaise
Patient was taking Kogenate (View Usage). Patient had the following side effects: loss of consciousness, malaise on Nov 07, 2008 from FRANCE Additional patient health information: Male patient , 24 years of age, was diagnosed with factor viii deficiency and. Kogenate dosage: .

6688024-5 | Factor Viii Inhibition, Haematoma
Adverse event was reported on Mar 11, 2010 by a Male patient taking Kogenate (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: FRANCE , child 3 years of age, After Kogenate was administered, patient had the following side effects: factor viii inhibition, haematoma.

6617109-4 | Factor Viii Inhibition, Haematoma
on Sep 17, 2008 Male patient from FRANCE , 57 years of age, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition, haematoma. Kogenate dosage: . During the same period patient was treated with HELIXATE (View Helixate Review and Helixate Label ).


6504801-5 | Factor Viii Inhibition, Venous Thrombosis
on Dec 01, 2009 Male patient from FRANCE , 45 years of age, weighting 158.7 lb, was diagnosed with immune system disorder and was treated with Kogenate (View Usage). Patient had the following side effects: factor viii inhibition, venous thrombosis. Kogenate dosage: .

6473976-9 | Factor Viii Inhibition, Muscle Haemorrhage
Patient was taking Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: factor viii inhibition, muscle haemorrhage on Nov 25, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 14 years of age, weighting 136.7 lb, was diagnosed with prophylaxis and. Kogenate dosage: . Patient was hospitalized.

6462164-8 | Cerebral Haemorrhage, Factor Viii Inhibition, Intracranial Haematoma
Adverse event was reported on Nov 23, 2009 by a Male patient taking Kogenate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: FRANCE , weighting 26.46 lb, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, factor viii inhibition, intracranial haematoma. Patient was hospitalized.

6419357-5 | Venous Thrombosis Limb
on Oct 22, 2009 Male patient from GERMANY , 39 years of age, weighting 154.3 lb, was diagnosed with factor viii inhibition and was treated with Kogenate (View Usage). Patient had the following side effects: venous thrombosis limb. Kogenate dosage: .

6405028-8 | Venous Thrombosis Limb
on Oct 07, 2009 Male patient from FRANCE , 39 years of age, weighting 154.3 lb, was diagnosed with factor viii inhibition and was treated with Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: venous thrombosis limb. Kogenate dosage: .

6366573-7 | Factor Viii Inhibition, Haematoma
Patient was taking Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition, haematoma on Sep 17, 2008 from FRANCE Additional patient health information: Male patient , 57 years of age, was diagnosed with factor viii deficiency and. Kogenate dosage: . During the same period patient was treated with HELIXATE (View Helixate Review and Helixate Label ). Patient was hospitalized.

6356325-6 | Factor Viii Inhibition, Haematoma
Adverse event was reported on Sep 11, 2009 by a Male patient taking Kogenate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: FRANCE , 57 years of age, weighting 132.3 lb, Patient had the following side effects: factor viii inhibition, haematoma. During the same period patient was treated with HELIXATE (View Helixate Review and Helixate Label ). Patient was hospitalized.

6309078-1 | Factor Viii Inhibition, Haemarthrosis, Haematuria, Haemorrhagic Diathesis, Injection Site Urticaria
on Aug 10, 2009 Male patient from GERMANY , child 9 years of age, weighting 97.00 lb, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: factor viii inhibition, haemarthrosis, haematuria, haemorrhagic diathesis, injection site urticaria. Kogenate dosage: 25 Times. Patient was hospitalized.

6256032-4 | Factor Viii Inhibition, Haemarthrosis, Haematuria, Haemorrhagic Diathesis, Injection Site Urticaria
on Jun 23, 2009 Male patient from GERMANY , child 9 years of age, weighting 97.00 lb, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition, haemarthrosis, haematuria, haemorrhagic diathesis, injection site urticaria. Kogenate dosage: 25 Times. Patient was hospitalized.

6252443-1 | Factor Viii Inhibition, Haematoma
Patient was taking Kogenate (View Usage). Patient had the following side effects: factor viii inhibition, haematoma on Jun 24, 2009 from FRANCE Additional patient health information: Male patient , 57 years of age, weighting 132.3 lb, was diagnosed with haemophilia and. Kogenate dosage: . Patient was hospitalized.

6227313-5 | Factor Viii Inhibition, Haemarthrosis, Haematuria, Haemorrhagic Diathesis, Injection Site Urticaria
Adverse event was reported on May 30, 2009 by a Male patient taking Kogenate (View Usage) (Dosage: 25 Times) was diagnosed with factor viii deficiency and. Location: GERMANY , child 9 years of age, weighting 97.00 lb, After Kogenate was administered, patient had the following side effects: factor viii inhibition, haemarthrosis, haematuria, haemorrhagic diathesis, injection site urticaria. Patient was hospitalized.

6180074-0 | Factor Viii Inhibition, Haemorrhagic Diathesis
on Nov 30, 2007 Male patient from UNITED KINGDOM , 40 years of age, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition, haemorrhagic diathesis. Kogenate dosage: .

6114481-9 | Factor Viii Inhibition, Pneumonia
on Mar 10, 2009 Male patient from GERMANY , child 7 years of age, was diagnosed with haemophilia, analgesia and was treated with Kogenate (View Usage). Patient had the following side effects: factor viii inhibition, pneumonia (What is pneumonia?). Kogenate dosage: . During the same period patient was treated with FEIBA (View Feiba Review and Feiba Label ), OROMORPH (View Oromorph Review and Oromorph Label ), TRANEXAMIC ACID (Total Daily Dose: 1.5 G) (View Tranexamic Acid Review and Tranexamic Acid Label ).

6022378-8 | Factor Viii Inhibition, Haemorrhage, Injury, Pneumonia
Patient was taking Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: factor viii inhibition, haemorrhage, injury, pneumonia (What is pneumonia?) on Dec 22, 2008 from GERMANY Additional patient health information: Male patient , child 7 years of age, was diagnosed with haemophilia, analgesia and. Kogenate dosage: . During the same period patient was treated with FEIBA (View Feiba Review and Feiba Label ), OROMORPH (View Oromorph Review and Oromorph Label ), TRANEXAMIC ACID (Total Daily Dose: 1.5 G) (View Tranexamic Acid Review and Tranexamic Acid Label ).

5975132-7 | Cerebral Haemorrhage, Factor Viii Inhibition, Intracranial Haematoma
Adverse event was reported on Nov 20, 2008 by a Male patient taking Kogenate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: FRANCE , weighting 26.46 lb, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, factor viii inhibition, intracranial haematoma.

5975067-X | Factor Viii Inhibition, Pneumonia
on Nov 17, 2008 Male patient from GERMANY , child 7 years of age, was diagnosed with haemophilia, analgesia and was treated with Kogenate (View Usage). Patient had the following side effects: factor viii inhibition, pneumonia (What is pneumonia?). Kogenate dosage: . During the same period patient was treated with FEIBA (View Feiba Review and Feiba Label ), OROMORPH (View Oromorph Review and Oromorph Label ), TRANEXAMIC ACID (Total Daily Dose: 1.5 G) (View Tranexamic Acid Review and Tranexamic Acid Label ).

5971711-1 | Factor Viii Inhibition, Pneumonia
on Nov 17, 2008 Male patient from GERMANY , child 7 years of age, was diagnosed with haemophilia, analgesia and was treated with Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: factor viii inhibition, pneumonia (What is pneumonia?). Kogenate dosage: . During the same period patient was treated with FEIBA (View Feiba Review and Feiba Label ), OROMORPH (View Oromorph Review and Oromorph Label ), TRANEXAMIC ACID (Total Daily Dose: 1.5 G) (View Tranexamic Acid Review and Tranexamic Acid Label ).

5889161-5 | Factor Viii Inhibition
Patient was taking Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition on Sep 12, 2008 from UNITED KINGDOM Additional patient health information: Male patient , child 7 years of age, . Kogenate dosage: . During the same period patient was treated with FEIBA (View Feiba Review and Feiba Label ), FANDHI (View Fandhi Review and Fandhi Label ).

5827440-8 | Factor Viii Inhibition, Haematoma
Adverse event was reported on Jul 24, 2008 by a Male patient taking Kogenate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: FRANCE , 57 years of age, Patient had the following side effects: factor viii inhibition, haematoma. During the same period patient was treated with HELIXATE (View Helixate Review and Helixate Label ). Patient was hospitalized.

5622727-6 | Hepatic Neoplasm Malignant
on Feb 06, 2008 Male patient from SWEDEN , 53 years of age, was treated with Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: hepatic neoplasm malignant. Kogenate dosage: . During the same period patient was treated with ATACAND / KANDESARTAN (View Atacand / Kandesartan Review and Atacand / Kandesartan Label ), CYKLOKAPRON / TRANEXAMSYRA (View Cyklokapron / Tranexamsyra Review and Cyklokapron / Tranexamsyra Label ), ZANTAC /RANITIDIN (View Zantac /ranitidin Review and Zantac /ranitidin Label ), IMOVANE /ZOPIKLON (View Imovane /zopiklon Review and Imovane /zopiklon Label ). Patient was hospitalized.

5605544-2 | Factor Viii Inhibition, Haematoma
on Jan 15, 2008 Male patient from FRANCE , 57 years of age, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition, haematoma. Kogenate dosage: . During the same period patient was treated with HELIXATE (View Helixate Review and Helixate Label ). Patient was hospitalized.

5603924-2 | Factor Viii Inhibition, Haematoma
Patient was taking Kogenate (View Usage). Patient had the following side effects: factor viii inhibition, haematoma on Jan 15, 2008 from FRANCE Additional patient health information: Male patient , 57 years of age, was diagnosed with factor viii deficiency and. Kogenate dosage: . During the same period patient was treated with HELIXATE (View Helixate Review and Helixate Label ). Patient was hospitalized.

5592753-4 | Factor Viii Inhibition, Haemorrhagic Diathesis
Adverse event was reported on Nov 30, 2007 by a Male patient taking Kogenate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: UNITED KINGDOM , 40 years of age, After Kogenate was administered, patient had the following side effects: factor viii inhibition, haemorrhagic diathesis.

5578843-0 | Factor Viii Inhibition, Haemorrhagic Diathesis
on Nov 30, 2007 Male patient from UNITED KINGDOM , 40 years of age, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition, haemorrhagic diathesis. Kogenate dosage: .

5553598-4 | Factor Viii Inhibition, Haemorrhagic Diathesis
on Nov 30, 2007 Male patient from UNITED KINGDOM , 40 years of age, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). Patient had the following side effects: factor viii inhibition, haemorrhagic diathesis. Kogenate dosage: .

5524596-1 | Hepatic Neoplasm Malignant
Patient was taking Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: hepatic neoplasm malignant on Nov 13, 2007 from NETHERLANDS Additional patient health information: Male patient , 50 years of age, was diagnosed with factor viii deficiency and. Kogenate dosage: .

5442978-3 | Factor Viii Inhibition, Haematoma, Impaired Healing, Wound Haemorrhage
Adverse event was reported on Aug 06, 2007 by a Male patient taking Kogenate (View Usage) (Dosage: See Image) was diagnosed with pilonidal sinus repair and. Location: GERMANY , 19 years of age, weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: factor viii inhibition, haematoma, impaired healing, wound haemorrhage. Patient was hospitalized.

5413028-X | Factor Viii Inhibition, Haematoma, Impaired Healing
on Jun 15, 2007 Male patient from GERMANY , 19 years of age, weighting 160.9 lb, was diagnosed with sinus operation and was treated with Kogenate (View Usage). Patient had the following side effects: factor viii inhibition, haematoma, impaired healing. Kogenate dosage: See Image. Patient was hospitalized.

5158083-X | Factor Viii Inhibition, Human Anti-mouse Antibody Positive
on Oct 31, 2006 Male patient from JAPAN , 32 years of age, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: factor viii inhibition, human anti-mouse antibody positive. Kogenate dosage: See Image.

5151927-7 | Antibody Test Positive, Factor Viii Inhibition
Patient was taking Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: antibody test positive, factor viii inhibition on Oct 31, 2006 from JAPAN Additional patient health information: Male patient , 32 years of age, was diagnosed with factor viii deficiency and. Kogenate dosage: 1000 Iu, Total Daily, Intravenous.

5145674-5 | Antibody Test Positive, Factor Viii Inhibition, False Positive Laboratory Result, Human Anti-mouse Antibody Positive
Adverse event was reported on Oct 10, 2006 by a Male patient taking Kogenate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: JAPAN , 36 years of age, Patient had the following side effects: antibody test positive, factor viii inhibition, false positive laboratory result, human anti-mouse antibody positive.

5145400-X | Factor Viii Inhibition, Human Anti-mouse Antibody Positive
on Oct 24, 2006 Male patient from JAPAN , 32 years of age, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: factor viii inhibition, human anti-mouse antibody positive. Kogenate dosage: 1000 Iu, Total Daily, Intravenous; See Image.

5140773-6 | Factor Viii Inhibition
on Sep 06, 2006 Male patient from JAPAN , 32 years of age, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition. Kogenate dosage: See Image, Intravenous.

5140626-3 | Anti Factor Viii Antibody Positive, Factor Viii Inhibition
Patient was taking Kogenate (View Usage). Patient had the following side effects: anti factor viii antibody positive, factor viii inhibition on Sep 06, 2006 from JAPAN Additional patient health information: Male patient , 32 years of age, was diagnosed with factor viii deficiency and. Kogenate dosage: See Image.

5000185-2 | Abasia, Haemarthrosis, Pain
Adverse event was reported on Apr 24, 2006 by a Male patient taking Kogenate (View Usage) (Dosage: 2000 Iu, Total Daily, Intravenous) was diagnosed with factor viii deficiency and. Location: NETHERLANDS , 15 years of age, weighting 110.2 lb, After Kogenate was administered, patient had the following side effects: abasia, haemarthrosis, pain (What is pain?).

4970272-3 | Abasia, Disease Recurrence, Haemarthrosis, Pain
on Mar 23, 2006 Male patient from NETHERLANDS , 15 years of age, weighting 110.2 lb, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, disease recurrence, haemarthrosis, pain (What is pain?). Kogenate dosage: 2000 Iu, Total Daily, Intravenous.

4713486-X | Hepatitis C, Hepatitis C Antibody Positive
on Aug 31, 2004 Male patient from UNITED STATES , weighting 85.00 lb, was diagnosed with factor viii deficiency and was treated with Kogenate (View Usage). Patient had the following side effects: hepatitis c (What is hepatitis c?), hepatitis c antibody positive. Kogenate dosage: Intravenous.

4664120-9 | Factor Viii Inhibition
Patient was taking Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: factor viii inhibition on Apr 28, 2005 from Additional patient health information: Male patient , 67 years of age, was diagnosed with surgery (What is surgery?) and. Kogenate dosage: 3 Kiu , Total Daily, Intravenous. During the same period patient was treated with HELIXATE (2 Kiu, Total Daily, Intravenous) (View Helixate Review and Helixate Label ). Patient was hospitalized.

4656527-0 | Cholecystitis Acute, Factor Viii Inhibition, Haematoma, Pericardial Haemorrhage
Adverse event was reported on Apr 22, 2005 by a Male patient taking Kogenate (View Usage) (Dosage: 3 Kiu, Total Daily, Intravenous) was diagnosed with surgery (What is surgery?) and. Location: , 67 years of age, Patient experienced the following unwanted or unexpected effects: cholecystitis acute, factor viii inhibition, haematoma, pericardial haemorrhage. During the same period patient was treated with HELIXATE (2 Kiu, Total Daily, Intravenous) (View Helixate Review and Helixate Label ), HELIXATE NEXGEN (OCTOLOG ALFA) (3 Kiu, Total Daily, Intravenous) (View Helixate Nexgen (octolog Alfa) Review and Helixate Nexgen (octolog Alfa) Label ). Patient was hospitalized.

4634145-8 | Anti Factor Viii Antibody Positive, Disease Recurrence, Haemarthrosis, Haematoma
on Mar 24, 2005 Male patient from , child 6 years of age, weighting 37.48 lb, was diagnosed with haemophilia and was treated with Kogenate (View Usage). Patient had the following side effects: anti factor viii antibody positive, disease recurrence, haemarthrosis, haematoma. Kogenate dosage: See Image. Patient was hospitalized.

4623441-6 | Disease Recurrence, Factor Viii Inhibition, Haemarthrosis, Haematoma
on Mar 11, 2005 Male patient from , child 6 years of age, weighting 37.48 lb, was diagnosed with haemophilia and was treated with Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: disease recurrence, factor viii inhibition, haemarthrosis, haematoma. Kogenate dosage: See Image. Patient was hospitalized.

4597109-9 | Factor Viii Inhibition
Patient was taking Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition on Feb 08, 2005 from Additional patient health information: Male patient , child 8 years of age, . Kogenate dosage: .

4577734-1 | Disease Recurrence, Factor Viii Inhibition, Haemarthrosis, Haematoma
Adverse event was reported on Jan 18, 2005 by a Male patient taking Kogenate (View Usage) (Dosage: Intravenous) was diagnosed with haemophilia and. Location: , child 6 years of age, Patient had the following side effects: disease recurrence, factor viii inhibition, haemarthrosis, haematoma. Patient was hospitalized.

4577010-7 | Factor Viii Inhibition
on Jan 12, 2005 Male patient from , child 8 years of age, was treated with Kogenate (View Usage). After Kogenate was administered, patient had the following side effects: factor viii inhibition. Kogenate dosage: .

4565238-1 | Inhibiting Antibodies
on Jan 12, 2005 Male patient from , 48 years of age, was treated with Kogenate (View Usage). Patient experienced the following unwanted or unexpected effects: inhibiting antibodies. Kogenate dosage: .